Role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in the management of bone and soft-tissue metastases.
about
Risk factors for lymphatic metastasis of malignant bone and soft-tissue tumors: a retrospective cohort study of 242 patients.Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.Role of FDG-PET/CT for monitoring soft tissue tumors.[Diagnosis of malignant bone and soft tissue tumors].Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis.
P2860
Role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in the management of bone and soft-tissue metastases.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Role of 2-deoxy-2-[F-18] fluor ...... ne and soft-tissue metastases.
@en
Role of 2-deoxy-2-[F-18] fluor ...... ne and soft-tissue metastases.
@nl
type
label
Role of 2-deoxy-2-[F-18] fluor ...... ne and soft-tissue metastases.
@en
Role of 2-deoxy-2-[F-18] fluor ...... ne and soft-tissue metastases.
@nl
prefLabel
Role of 2-deoxy-2-[F-18] fluor ...... ne and soft-tissue metastases.
@en
Role of 2-deoxy-2-[F-18] fluor ...... ne and soft-tissue metastases.
@nl
P2093
P1476
Role of 2-deoxy-2-[F-18] fluor ...... ne and soft-tissue metastases.
@en
P2093
H Watanabe
K Takagishi
T Shinozaki
T Yanagawa
P304
P356
10.1302/0301-620X.92B3.23131
P577
2010-03-01T00:00:00Z